Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

Blood (2023) 142 (16): 1387–1398.

https://doi.org/10.1182/blood.2023020026

Published: 2023

Includes: Supplemental data

Journal Articles

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Blood (2022) 140 (Supplement 1): 12938–12940.

https://doi.org/10.1182/blood-2022-162484

Published: 2022

Journal Articles

Comparative Analysis of Alpha-Beta T-Cell and B-Cell Depleted (abTCD) HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT) Versus Abtcd Haplo-HSCT with T-Cell Add-Back of Rivogenlecleucel Cell [Donor T Cells Transduced with the Inducible Caspase 9 (iC9) Gene Safety Switch] in Children with High-Risk Acute Leukemia (AL) in Remission

Annalisa Ruggeri, MD, Pietro Merli, MD, Mattia Algeri, MD, Marco Zecca, Franca Fagioli, MD, Giuseppina Li Pira, PhD, Valentina Bertaina, PhD, Arcangelo Prete, MD, Mauro Montanari, MD, Francesca Del Bufalo, MD, Luciana Vinti, MD, Daria Pagliara, MD PhD, Melissa Aldinger, PharmD, Kai Chan, Paul Woodard, Federica Galaverna, MD, Franco Locatelli, MD

Blood (2019) 134 (Supplement_1): 145.

https://doi.org/10.1182/blood-2019-125366

Published: 2019

Journal Articles

Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia

Blood (2018) 132 (24): 2594–2607.

https://doi.org/10.1182/blood-2018-07-861575

Published: 2018

Includes: Supplemental data

Journal Articles

Steroid-Refractory Acute Gvhd in Children: Retrospective Analysis of the AIEOP HSCT Registry

Marco Zecca, MD, Daria Pagliara, MD PhD, Franca Fagioli, MD, Attilio Rovelli, MD, Edoardo Lanino, MD, Arcangelo Prete, MD, Elisabetta Calore, MD, Stella Boghen, MD, Pietro Merli, MD, Francesca Compagno, MD, Mimmo Ripaldi, MD, Fulvio Porta, MD, Franco Locatelli

Blood (2018) 132 (Supplement 1): 4578.

https://doi.org/10.1182/blood-2018-99-114862

Published: 2018

Journal Articles

Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network

Blood (2017) 130 (Supplement 1): 4554.

https://doi.org/10.1182/blood.V130.Suppl_1.4554.4554

Published: 2017

Journal Articles

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Andre Manfred Willasch, MD, Christina Peters, MD, Petr Sedlacek, MD, Jean-Hugues Dalle, MD, Stelios Graphakos, MD, Akif Yesilipek, MD, Jacek Wachowiak, Prof MDPhD, Arjan Lankester, MD PhD, Arcangelo Prete, MD, Amir Ali Hamidieh, MD, Marianne Ifversen, Jochen Büchner, MDPhD, Gergely Krivan, MD, Rose-Marie Hamladji, MD, Cristina Diaz de Heredia, MD, Elena Skorobogatova, MD PhD, Gerard Michel, MD, Franco Locatelli, MD PhD, Alice Bertaina, MD PhD, Paul Veys, MD, Sophie Dupont, MD, Reuven Or, MD, Tayfun Guengoer, Olga Aleinikova, MD PhD, Sabina Sufliarska, MD, Mikael Sundin, MD PhD, Jelena Rascon, MD, Ain Kaare, MD, Damir Nemet, MD PhD, Franca Fagioli, MD, Thomas Klingebiel, MD, Jan Styczynski, PhD, Marc B Bierings, MDPhD, Kalman Nagy, MD, Manuel Abecasis, MD, Boris V Afanasyev, MD PhD Professor, Marc Ansari, MD, Arnaud Dalissier, Myriam Labopin, MD, Eric Beohou, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 911.

https://doi.org/10.1182/blood.V130.Suppl_1.911.911

Published: 2017

Journal Articles

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Franco Locatelli, MD, Maria Ester Bernardo, MD, Alice Bertaina, MD PhD, Carla Rognoni, PhD, Patrizia Comoli, MD, Attilio Rovelli, MD, Andrea Pession, MD PhD, Franca Fagioli, MD, Claudio Favre, MD, Edoardo Lanino, MD, Giovanna Giorgiani, MD, Pietro Merli, MD, Arcangelo Prete, MD, Marco Zecca, MD

Blood (2016) 128 (22): 1168.

https://doi.org/10.1182/blood.V128.22.1168.1168

Published: 2016

Journal Articles

Hematopoietic Stem Cell Transplantation for Hemophagocytic Lymphohistiocitosis : A National Retrospective Analysis of Data from the Italian Association of Pediatric Hematology Oncology (AIEOP)

Blood (2015) 126 (23): 621.

https://doi.org/10.1182/blood.V126.23.621.621

Published: 2015

Journal Articles

Role of Allogeneic Hematopoietic Stem Cell Transplantation in t(4;11) Positive Acute Lymphoblastic Leukemia (ALL): A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

Luca Lo Nigro, Marco Zecca, MD, Franca Fagioli, MD, Edoardo Lanino, Chiara Messina, Marco Rabusin, MD, Domenico Ripaldi, MD, Attilio Rovelli, MD, Arcangelo Prete, Franco Locatelli

Blood (2014) 124 (21): 1243.

https://doi.org/10.1182/blood.V124.21.1243.1243

Published: 2014

Journal Articles

Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry.

Franca Fagioli, MD, Paola Quarello, MD, Marco Zecca, Edoardo Lanino, MD, Carla Rognoni, Adriana Balduzzi, MD, Chiara Messina, MD, Claudio Favre, MD, Roberto Foà, Mimmo Ripaldi, MD, Sergio Rutella, Giuseppe Basso, MD, Arcangelo Prete, Franco Locatelli, Prof, MD, PhD

Blood (2012) 120 (21): 3036.

https://doi.org/10.1182/blood.V120.21.3036.3036

Published: 2012

Journal Articles

No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission

Giorgio Dini, Marco Zecca, Adriana Balduzzi, Chiara Messina, Riccardo Masetti, Franca Fagioli, Claudio Favre, Marco Rabusin, Fulvio Porta, Erika Biral, Mimmo Ripaldi, Anna Paola Iori, Carla Rognoni, Arcangelo Prete, Franco Locatelli

Blood (2011) 118 (25): 6683–6690.

https://doi.org/10.1182/blood-2011-05-354233

Published: 2011

Includes: Supplemental data

Journal Articles

Fludarabine, Cyclophosphamide, Anti-Thymocyte Globulin, with or without “ 2Gy TBI, for Alternative Donor Transplants in Acquired Aplastic Anemia (SAA): A Report From the EBMT-SAA Working Party.

Andrea Bacigalupo, Gerard Socie', Edoardo Lanino, Arcangelo Prete, Franco Locatelli, Anna Locasciulli, Simone Cesaro, Avicahi Shimoni, Judith Marsh, Mats L Brune, Jakob R. Passweg

Blood (2009) 114 (22): 1207.

https://doi.org/10.1182/blood.V114.22.1207.1207

Published: 2009

Journal Articles

Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan.

Marco Zecca, Riccardo Masetti, Adriana Balduzzi, Franca Fagioli, Giorgio Dini, Chiara Messina, Attilio Rovelli, Luca Lo Nigro, Mario Regazzi, Giuseppe Basso, Andrea Pession, Arcangelo Prete, Franco Locatelli

Blood (2009) 114 (22): 2288.

https://doi.org/10.1182/blood.V114.22.2288.2288

Published: 2009

Journal Articles

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Arcangelo Prete, MD, Federico Bonetti, MD, Roberto Rondelli, MD, Simone Cesaro, MD, Sandro Dallorso, MD, Claudio Favre, MD, Franca Fagioli, MD, Chiara Messina, MD, Roberta Burnelli, MD, Franco Locatelli, MD, Andrea Pession, MD

Blood (2005) 106 (11): 2088.

https://doi.org/10.1182/blood.V106.11.2088.2088

Published: 2005

Journal Articles

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Arcangelo Prete, MD, Antonella Bartoli, MD, Claudia Castellini, MD, Roberto Rondelli, MD, Riccardo Masetti, MD, Andrea Pession, MD, Mario Regazzi-Bonora, MD

Blood (2005) 106 (11): 5320.

https://doi.org/10.1182/blood.V106.11.5320.5320

Published: 2005

Journal Articles

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome

Marco Zecca, Arcangelo Prete, Roberto Rondelli, Edoardo Lanino, Adriana Balduzzi, Chiara Messina, Franca Fagioli, Fulvio Porta, Claudio Favre, Andrea Pession, Franco Locatelli

Blood (2002) 100 (4): 1192–1200.

https://doi.org/10.1182/blood-2001-11-0059

Published: 2002

Journal Articles

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

Franco Locatelli, Marco Zecca, Roberto Rondelli, Federico Bonetti, Giorgio Dini, Arcangelo Prete, Chiara Messina, Cornelio Uderzo, Mimmo Ripaldi, Fulvio Porta, Giovanna Giorgiani, Eugenia Giraldi, Andrea Pession

Blood (2000) 95 (5): 1572–1579.

https://doi.org/10.1182/blood.V95.5.1572.005k12_1572_1579

Published: 2000

NARROW

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia

Steroid-Refractory Acute Gvhd in Children: Retrospective Analysis of the AIEOP HSCT Registry

Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Hematopoietic Stem Cell Transplantation for Hemophagocytic Lymphohistiocitosis : A National Retrospective Analysis of Data from the Italian Association of Pediatric Hematology Oncology (AIEOP)

Role of Allogeneic Hematopoietic Stem Cell Transplantation in t(4;11) Positive Acute Lymphoblastic Leukemia (ALL): A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry.

No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission

Fludarabine, Cyclophosphamide, Anti-Thymocyte Globulin, with or without “ 2Gy TBI, for Alternative Donor Transplants in Acquired Aplastic Anemia (SAA): A Report From the EBMT-SAA Working Party.

Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan.

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only